1,023
Participants
Start Date
September 30, 2015
Primary Completion Date
June 28, 2019
Study Completion Date
July 3, 2019
Ad26.ZEBOV
Ebola Zaire vaccine, replication incompetent vaccine, sterile suspension of 0.5 milliliter (mL) intramuscular (IM) injection of 5\*10\^10 viral particles.
MVA-BN-Filo
MVA-BN-Filo- is a non-replicating vaccine, 0.5 mL IM injection of 1\*10\^8 Infectious Unit (Inf. U.).
MenACWY
MenACWY is a WHO-prequalified Meningococcal Group A, C, W135 and Y conjugate vaccine.
Placebo
0.9% saline for injection.
Freetown
Collaborators (1)
London School of Hygiene and Tropical Medicine
OTHER
Ministry of Health and Sanitation, Sierra Leone
OTHER_GOV
University of Sierra Leone
OTHER
University of Oxford
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Grameen Foundation
OTHER
World Vision, Ireland
OTHER
Janssen Vaccines & Prevention B.V.
INDUSTRY